Publisher Correction: Antibody engineers seek optimal drug targeting TIGIT checkpoint
- PMID: 32999474
- DOI: 10.1038/s41587-020-0714-x
Publisher Correction: Antibody engineers seek optimal drug targeting TIGIT checkpoint
Abstract
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Erratum for
-
Antibody engineers seek optimal drug targeting TIGIT checkpoint.Nat Biotechnol. 2020 Sep;38(9):1007-1009. doi: 10.1038/s41587-020-0666-1. Nat Biotechnol. 2020. PMID: 32887966 No abstract available.
Publication types
LinkOut - more resources
Full Text Sources
